Latest filing published 20 Mar 2008 for Halozyme Therapeutics, INC., €15k.
Insider track record
No signal scores available.
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -25.7%Entry US$6.72 · Close at T+365 US$4.99
- -21.0%Entry US$8.51 · Close at T+365 US$6.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Little: trading record in brief
Robert J. Little is a declared insider of Halozyme Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 10 filings; the first trade dates from 19 March 2007 and the latest from 20 March 2008.
Purchases make up the whole of the open-market record (10 purchases, €87k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2008 alone, the filings show 4 purchases and no sales.
In size, the median ticket on the buying side is €5,163. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 43% of cases, with a median move of -13.1%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 20 March 2008, reports an open-market purchase of €15k in Halozyme Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert J. Little
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,800 shares@ US$5.96Common StockSEC:0001418145-08-000016:0Canonical exit: 18 Jun 2008 (T+90)
- 2,000 shares@ US$5.97Common StockSEC:0001418145-08-000016:1Canonical exit: 18 Jun 2008 (T+90)
- 200 shares@ US$5.98Common StockSEC:0001418145-08-000016:2Canonical exit: 18 Jun 2008 (T+90)
- 3,000 shares@ US$5.99Common StockSEC:0001418145-08-000016:3Canonical exit: 18 Jun 2008 (T+90)
- 3,200 shares@ US$8.65Common StockSEC:0001181431-07-020269:0Canonical exit: 17 Jun 2007 (T+90)
- 400 shares@ US$8.63Common StockSEC:0001181431-07-020269:1Canonical exit: 17 Jun 2007 (T+90)
- 400 shares@ US$8.62Common StockSEC:0001181431-07-020269:2Canonical exit: 17 Jun 2007 (T+90)
7 of 7 declarations
